Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
SFOSF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $12,958,746 | $13,715,963 | $13,523,933 | $13,507,968 |
| Short-Term Investments | $2,679,964 | $2,353,922 | $2,595,997 | $2,122,081 |
| Receivables | $9,959,320 | $9,350,262 | $9,430,022 | $9,820,187 |
| Inventory | $6,743,729 | $6,823,050 | $7,258,649 | $7,435,227 |
| Other Curr. Assets | $2,000,509 | $2,195,413 | $1,682,460 | $1,641,836 |
| Total Curr. Assets | $34,342,268 | $34,438,610 | $34,491,061 | $34,527,299 |
| Property Plant & Equip (Net) | $23,983,098 | $23,656,792 | $23,410,549 | $21,861,334 |
| Goodwill | $10,926,091 | $10,888,058 | $10,905,083 | $10,800,669 |
| Intangibles | $19,564,929 | $19,404,692 | $19,336,238 | $17,927,764 |
| Long-Term Investments | $0 | $23,881,611 | $23,269,067 | $25,978,119 |
| Tax Assets | $747,646 | $754,081 | $757,776 | $791,145 |
| Other NC Assets | $29,263,905 | $4,966,645 | $5,290,793 | $3,378,432 |
| Total NC Assets | $84,485,669 | $83,551,879 | $82,969,507 | $80,737,462 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $118,827,937 | $117,990,489 | $117,460,567 | $115,264,762 |
| Liabilities | – | – | – | – |
| Payables | $5,449,859 | $5,438,826 | $5,997,385 | $5,525,583 |
| Short-Term Debt | $17,861,511 | $17,874,459 | $18,711,315 | $18,679,640 |
| Tax Payable | $466,938 | $649,017 | $560,735 | $537,017 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $12,245,029 | $11,538,235 | $12,183,234 | $12,775,343 |
| Total Curr. Liab. | $36,023,337 | $35,500,537 | $37,452,669 | $37,517,582 |
| LT Debt | $14,349,086 | $14,189,912 | $12,985,468 | $11,087,420 |
| Deferred Rev, NC | $675,083 | $649,905 | $657,891 | $605,077 |
| Deferred Tax Liab, NC | $3,388,833 | $3,444,772 | $3,245,159 | $3,464,987 |
| Other NC Liab. | $4,076,490 | $3,355,460 | $3,185,652 | $3,395,091 |
| Total NC Liab. | $22,489,492 | $21,640,050 | $20,074,169 | $18,552,575 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2,754,163 | $2,629,469 | $2,541,968 | $2,217,237 |
| Total Liabilities | $58,512,829 | $57,140,587 | $57,526,838 | $56,070,158 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $2,670,429 | $2,671,326 | $2,671,326 | $2,671,326 |
| Retained Earnings | $27,412,519 | $27,317,816 | $26,553,059 | $25,827,907 |
| AOCI | $0 | $0 | $0 | $19,009,135 |
| Other Equity | $17,314,675 | $17,934,489 | $18,036,722 | -$206,895 |
| Total Equity | $47,397,624 | $47,923,632 | $47,261,107 | $47,301,473 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $12,917,485 | $12,926,270 | $12,672,622 | $11,893,131 |
| Total Liab. & Tot. Equity | $118,827,937 | $117,990,489 | $117,460,567 | $115,264,762 |
| Net Debt | $19,251,851 | $18,348,408 | $18,172,849 | $16,259,092 |